Improvement in Tc-99m HMPAO brain SPECT findings during donepezil therapy in a patient with pure akinesia

Annals of Nuclear Medicine

Volumn 19, Issue 7, 2005, Pages 607-609

  Yener, Gorsev G ^a   Kaya, Gamze Çapa ^a   Öztürk, Vesile ^a   Akdal, Gulden ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Donepezil; Pure akinesia; Tc 99m HMPAO brain SPECT

Indexed keywords

DONEPEZIL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; LEVODOPA; SELEGILINE;

ADULT; AKINESIA; ARTICLE; BRAIN PERFUSION; CASE REPORT; DRUG RESPONSE; FRONTAL CORTEX; GAIT DISORDER; HUMAN; MALE; MENINGOENCEPHALITIS; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPEECH DISORDER; VIDEORECORDING;

ALEXIA, PURE; BRAIN; CHOLINESTERASE INHIBITORS; DEMENTIA; GAIT DISORDERS, NEUROLOGIC; INDANS; NEURODEGENERATIVE DISEASES; PIPERIDINES; RADIOPHARMACEUTICALS; RECOVERY OF FUNCTION; SYNDROME; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 31544475405     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985055     Document Type: Article

References (15)

1. Imai H. Clinicophysiological features of akinesia. Eur Neurol 1996; 36 Suppl 1: 9-12.
2. Davis PH, Bergeron C, Mc Lachlan DR. Atypical presentation of progressive supranuclear palsy. Ann Neurol 1985; 17: 337-343.
3. Pramsteller PP, Salerno A, Bhatia KP, Prugger M, Marsden CD. Primary central nervous system lymphoma presenting with a parkinsonian syndrome of pure akinesia. J Neurol 1999; 246: 934-938.
4. Umahara T, Kano H, Iwamoto T, Katsunuma H, Tachikawa K, Tachikawa S. An MRI and SPECT study of frozen gait without other manifestations of parkinsonism in the elderly. Nippon Ronen Igakkai Zasshi 1991; 28: 377-384.
5. Watanabe H, Arahata Y, Tadokoro M, Kato T, Sobue G. Effects of tandospirone citrate on frozen gait in patients with elderly stage of progressive supranuclear palsy, investigated by walk-induced activation single photon emission computed tomography method. Rinsho Shinkeigaku 2000; 40: 1130-1132.
6. Quinn NP, Luthert P, Honavar M, Marsden CD. Pure akinesia due to Lewy body Parkinson's disease: a case with pathology. Mov Disord 1989; 41: 85-89.
7. Yamamoto T, Kawamura J, Hashimoto S, Nakamura M, Iwamoto H, Kobashi Y, et al. Pallido-nigro-luysian atrophy, progressive supranuclear palsy and adult onset Hallervorden-Spatz disease: a case of akinesia as a predominant feature of parkinsonism. J Neurol Sci 1991; 101: 98-106.
8. Bogousslavsky J, Regli F, Delaloye B, Delaloye Bischof A, Assal G, Uske A. Loss of psychic self-activation with bithalamic infarction. Neurobehavioural, CT, MRI and SPECT correlates. Acta Neurol Scand 1991; 83: 309-316.
9. Lass P, Slawek J, Derejko M, Dubaniewicz M. Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy. Neurol Neurochir Pol 2003; 37: 263-274.
10. Antonini A, Benti R, De Notaris T, Tesei S, Zecchinelli A, Sacilotto G, et al. I-123 ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson' disease, multiple system atrophy, and progressive supranuclear palsy. Neurol Sci 2003; 24: 149-150.
11. Boeve B, Dickson D, Duffy J, Bartleson J, Trenerry M, Petersen R. Progressive nonfluent aphasic dementia associated with atypical progressive nuclear palsy pathology. Eur Neurol 2003; 49: 72-78.
12. Zhang L, Murata Y, Ishida R, Saitoh Y, Mizusawa H, Shibuya H. Differentiating between progressive supranuclear palsy and corticobasal degeneration by brain perfusion SPET. Nucl Med Commun 2001; 22: 767-772.
13. Okuda B, Tachibana H, Kawabata K, Takeda M, Sugita M. Cerebral blood flow in corticobasal degeneration and progressive supranuclear palsy. Alzheimer Dis Assoc Disord 2000; 14: 46-52.
14. Zakzanis KK, Leach L, Freedman M. Structural and functional meta-analytic evidence for fronto-subcortical system deficit in progressive supranuclear palsy. Brain Cogn 1998; 38: 283-296.
15. Johnson KA, Sperling RA, Leonard HB, Steven NJ, Growdon JH. Cerebral perfusion in progressive supranuclear palsy. Neurology 1999; 53: 502-507.